ALK and neoplasm: A 48-year-old male was diagnosed with lung adenocarcinoma, cT4N3M1a, stage IVA with <i>ALK</i> rearrangement, high PD-L1 expression with a tumor proportion score (TPS) of 100%, and MSI-high.